Skip to main content

Dr. Ada Adimora named 2021 Summit Honoree

November 12, 2021

On November 10th, Dr. Ada Adimora was named the honoree at the 2021 “Where She Leads We Will Follow Her: National Women’s Summit on HIV and Health.” We are exceedingly proud of Dr. Adimora for her work, and think she is most deserving of this honor. Follow this link to view a portion of the … Read more

Browne Lab Earns NIH Grant to Study Cannabis Effects on HIV Reservoir

July 12, 2021

“Ed Browne, PhD, assistant professor of medicine, is the principal investigator of a $4-million, 5-year study of the role of cannabis use in HIV latency – one of the main barriers toward curing people with the infection. The National Institute on Drug Abuse, part of the NIH, is funding the Browne lab in the UNC HIV … Read more

Expecting the unexpected

August 11, 2020

Carolina experts are leveraging 40 years of HIV research to find a treatment for COVID-19.  The Well recently published an article detailing UNC’s expertise in the field of HIV research and how this has influenced the research response to COVID-19. CFAR Associate Director Dr. Myron Cohen notes, “HIV has taught us how to approach problems … Read more

ViiV Healthcare, UNCCH announce five-year, $20 million renewal of HIV cure partnership

March 13, 2020

“This unique public-private collaboration provides funding for HIV Cure Center and Qura Therapeutics, the joint venture that brings academic and pharmaceutical research scientists together for the goal of curing people with HIV. David Margolis, MD, is the director of the UNC Cure Center. ViiV Healthcare and the University of North Carolina at Chapel Hill announced … Read more

National Geographic selects the multinational HPTN 052 HIV trial, led by Myron Cohen, MD, as one of the discoveries of the decade

January 2, 2020

“National Geographic published an article about the top 20 scientific discoveries on the decade, including  the treatment of HIV as prevention, a concept based on Myron Cohen’s multinational HPTN 052 trial, which demonstrated that antiretroviral treatment of people with HIV infection prevents the sexual transmission of the virus. This study served as the basis for HIV “treatment … Read more

NC, SC Join Forces to Combat HIV Epidemic

July 12, 2019

Both state health departments and HIV researchers at flagship universities announced the new “Carolinas United to End HIV (CUE-HIV)” partnership to decrease the number of HIV infections by 90 percent in ten years. July 8, 2019 CHAPEL HILL, NC – Health officials and leading researchers in North Carolina and South Carolina have created a new … Read more

UNC CFAR at CROI 2019: Recordings Available

February 27, 2019

Keep tabs on UNC CFAR’s presence at the 2019 Conference on Retroviruses and Opportunistic Infections, held in Seattle, WA March 4-7. Now updated with recordings. Plenary Wednesday, 8:30-9:30AM: 8:30AM #67: Raising the Wall in Maternal/Fetal Immunity Plenary PL-2, Auditorium – 4AB Sallie Permar Watch recording Thursday, 8:30-9:30AM: 9AM #121: “NeuroHIV: What the Virus Tells Us” … Read more

Ongoing Projects: From Cape Town to Wake County

February 21, 2019

February Updates In collaboration with the South African Medical Research Council, UNC CFAR and RTI International have continued their work with the Cape Town Young Women’s Health CoOp (YWHC). This YWHC is a gender-focused intervention aimed at out-of-school young women living in one of the global epicenters of HIV infection. Principal Investigator Wendee Wechsberg’s team … Read more

Developmental RFP Application now Available!

November 20, 2018

The application for the 2019-2020 Developmental RFP is now open! Applications are due December 10, 2018. To learn more, click the RFP tab on the developmental core page.

Intervention Improves Adherence, Decreases Mortality

September 5, 2018

UNC researchers were part of a team that found an integrated intervention increased HIV medication uptake and decreased mortality among people living with HIV who inject drugs at three international sites. Their results were published in The Lancet. The study, HIV Prevention Trials Network (HPTN) 074, assessed an integrated intervention combining psychosocial counseling and supported … Read more

Floris-Moore Joins HIVMA Board

July 19, 2018

Members of the HIV Medicine Association elected Michelle Floris-Moore, MD, MS, to its Board of Directors. Floris-Moore is an associate professor of medicine in the Division of Infectious Diseases and the director of UNC’s Infectious Diseases Fellowship Training Program. She cares for people living with HIV in the UNC Infectious Diseases Clinic, and researches the … Read more